The U.S. market for Progesterone Active Pharmaceutical Ingredient (API) is showing signs of a potential turnaround as it enters xxxx, following a period of price stability that saw rates settle at USD xxxxxx per metric ton in December. Market analysts are pointing to several key factors that could drive a significant shift in pricing dynamics for this crucial pharmaceutical raw material.
The anticipated recovery in Progesterone prices comes after a challenging period characterized by weak demand and high inventory levels, which had previously dampened trading activity. However, industry experts suggest that the market is now positioning for a rebound, particularly as global supply chains continue to normalize following recent disruptions and seasonal slowdowns.
A notable factor influencing this expected market shift is the strength of the U.S. dollar, which maintained robust performance through late xxxx. The currency&#xx;s position is projected to create favorable conditions for U.S....
